Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
This model, developed by the Chinese University of Hong Kong and Beijing Tongren Hospital, is now being deployed across China's Henan Province to diagnose common eye diseases.